These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35252632)

  • 1. Fluconazole resistant
    Shahi G; Kumar M; Skwarecki AS; Edmondson M; Banerjee A; Usher J; Gow NAR; Milewski S; Prasad R
    Cell Surf; 2022 Dec; 8():100076. PubMed ID: 35252632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of PTR transporters in Candida species and their functional characterization in Candida auris.
    Khatoon R; Sharma S; Prasad R; Lynn AM; Prakash A; Banerjee A
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):4223-4235. PubMed ID: 35648145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of thionated analogues of Nva-FMDP and Lys-Nva-FMDP.
    Nowak-Jary J; Andruszkiewicz R
    Pol J Microbiol; 2009; 58(4):295-9. PubMed ID: 20380139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase.
    Milewski S; Andruszkiewicz R; Kasprzak L; Mazerski J; Mignini F; Borowski E
    Antimicrob Agents Chemother; 1991 Jan; 35(1):36-43. PubMed ID: 1901701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative fitness trade-offs associated with azole resistance in
    Das S; Singh S; Tawde Y; Dutta TK; Rudramurthy SM; Kaur H; Shaw T; Ghosh A
    Heliyon; 2024 Jun; 10(12):e32386. PubMed ID: 38988564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in
    Rybak JM; Muñoz JF; Barker KS; Parker JE; Esquivel BD; Berkow EL; Lockhart SR; Gade L; Palmer GE; White TC; Kelly SL; Cuomo CA; Rogers PD
    mBio; 2020 May; 11(3):. PubMed ID: 32398311
    [No Abstract]   [Full Text] [Related]  

  • 7. Delineation of the Direct Contribution of Candida auris
    Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
    Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
    Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
    Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance
    Burrack LS; Todd RT; Soisangwan N; Wiederhold NP; Selmecki A
    mBio; 2022 Aug; 13(4):e0084222. PubMed ID: 35862787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging Anticancer Activity of Candidal Glucoseamine-6-Phosphate Synthase Inhibitors upon Nanoparticle-Mediated Delivery.
    Kertmen A; Przysiecka Ł; Coy E; Popenda Ł; Andruszkiewicz R; Jurga S; Milewski S
    Langmuir; 2019 Apr; 35(15):5281-5293. PubMed ID: 30912436
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
    Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diffusible analogue of N(3)-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid with antifungal activity.
    Zgódka D; Milewski S; Borowski E
    Microbiology (Reading); 2001 Jul; 147(Pt 7):1955-1959. PubMed ID: 11429472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP.
    Milewski S; Mignini F; Covelli I; Borowski E
    J Med Vet Mycol; 1994; 32(1):1-11. PubMed ID: 8207618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticandidal properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid oligopeptides.
    Andruszkiewicz R; Milewski S; Zieniawa T; Borowski E
    J Med Chem; 1990 Jan; 33(1):132-5. PubMed ID: 2104933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris.
    Iyer KR; Whitesell L; Porco JA; Henkel T; Brown LE; Robbins N; Cowen LE
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156828
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    O'Brien B; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomics and Phenotyping Define Genetic Signatures Associated with Echinocandin Resistance in Candida auris.
    Jenull S; Shivarathri R; Tsymala I; Penninger P; Trinh PC; Nogueira F; Chauhan M; Singh A; Petryshyn A; Stoiber A; Chowdhary A; Chauhan N; Kuchler K
    mBio; 2022 Aug; 13(4):e0079922. PubMed ID: 35968956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of the emerging pathogenic yeast
    Lara-Aguilar V; Rueda C; García-Barbazán I; Varona S; Monzón S; Jiménez P; Cuesta I; Zaballos Á; Zaragoza Ó
    Virulence; 2021 Dec; 12(1):1400-1417. PubMed ID: 34180774
    [No Abstract]   [Full Text] [Related]  

  • 20. Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures.
    Kumar M; Singh A; Kumari S; Kumar P; Wasi M; Mondal AK; Rudramurthy SM; Chakrabarti A; Gaur NA; Gow NAR; Prasad R
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158815. PubMed ID: 32942047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.